Product specific indication and dosing:

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

For those IVIG products which have the indication CIDP, the dosing generally consists of a loading dose at 2 g/kg (given over 2–5 days) followed by maintenance doses of 1 g/kg (given over 1–2 days), cautioning physicians that the duration of treatment beyond 24 weeks should be subject to their discretion based upon the patient’s response and maintenance response in the long-term and further that the dosing and intervals may have to be adapted according to the individual course of the disease.

No current IVIG/SCIG coreSPC indication or dosing available.